Skip to content

Applied research of Excimer Laser Ablation combined with drug-coated balloon treated in vasculopathy below the knee of elderly diabetic foot

Applied research of Excimer Laser Ablation combined with drug-coated balloon treated in vasculopathy below the knee of elderly diabetic foot

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021183
Enrollment
Unknown
Registered
2019-02-01
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly diabetic foot

Interventions

the experiment group:Excimer Laser Ablation combined with drug-coated balloon
the control group:drug-coated balloon

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of diabetic foot; 2. Resting Ankle brachial index(ABI) <0.9; 3. CTA or color doppler ultrasound reveal that infrapopliteal artery occlusion or stenosis; 4. Diabetic foot grading: Wagner level 1-4; 5. Older than 60 years old; 6. Agreed to get into the group.

Exclusion criteria

Exclusion criteria: 1. Diabetic foot (Wagner level 0 and level 5): Wagner level 0: no ulcer, Wagner 5: severe infection up to amputation; 2. Guide wire cannot pass through diseased region, no inflow and outflow tract, cannot use endovascular treatment; 3. Refuse to use Excimer Laser Ablation (ELA); 4. Already treated by drug-coated balloon (DCB) or bypass angioplasty; 5. Has contraindication of endovascular treatment, severe organ dysfunction, renal insufficiency cannot tolerance to contrast medium, contrast medium allergy.

Design outcomes

Primary

MeasureTime frame
Target lesion patency rate in twelve months after surgery;

Secondary

MeasureTime frame
Late lumen loss(LLL) in twelve months after surgery;Target lesion revascularization(TLR) in three month after surgery;Target lesion revascularization(TLR) in six month after surgery;Target lesion revascularization(TLR) in twelve month after surgery;Ulcer healing rate in one month after surgery;Ulcer healing rate in three month after surgery;Ulcer healing rate in six month after surgery;Ulcer healing rate in twelve month after surgery;Limb preserved rates;Adverse event rates;

Countries

China

Contacts

Public ContactJu He

Tianjin First Central Hospital

172730830@qq.com+86 022-23627520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026